Novartis Ag Stock Price on March 8, 2022
| NVSEF Stock | USD 96.00 0.89 0.94% |
If you're considering investing in Novartis Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Novartis stands at 96.00, as last reported on the 25th of April, with the highest price reaching 96.74 and the lowest price hitting 95.36 during the day. Novartis AG has Sharpe Ratio of -0.0773, which conveys that the firm had a -0.0773% return per unit of risk over the last 3 months. Novartis exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Novartis' Standard Deviation of 1.7, risk adjusted performance of (0.05), and Mean Deviation of 1.11 to check out the risk estimate we provide.
Novartis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Novartis |
Sharpe Ratio = -0.0773
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVSEF |
Estimated Market Risk
| 1.69 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novartis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novartis by adding Novartis to a well-diversified portfolio.
Novartis Valuation on March 8, 2022
It is possible to determine the worth of Novartis on a given historical date. On March 8, 2022 Novartis was worth 91.35 at the beginning of the trading date compared to the closed value of 83.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Novartis pink sheet. Still, in general, we apply an absolute valuation method to find Novartis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novartis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Novartis' related companies.
| Open | High | Low | Close | Volume | |
04/11/2022 | 91.35 | 91.35 | 83.09 | 83.09 | 61.00 |
| 91.49 | 91.69 | 83.40 | 83.40 | 35,805 |
| Backtest Novartis | | | Novartis History | | | Novartis Valuation | Next |
Novartis Trading Date Momentum on March 8, 2022
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Novartis AG Fundamentals Correlations and Trends
By evaluating Novartis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Novartis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Novartis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Novartis Pink Sheet history
Novartis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novartis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novartis AG will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novartis stock prices may prove useful in developing a viable investing in Novartis
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 104323 people.
Novartis Pink Sheet Technical Analysis
Novartis technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Novartis Period Price Range
Low | April 11, 2022
| High |
91.35 | 83.09 |
Novartis April 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Novartis pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novartis shares will generate the highest return on investment. By undertsting and applying Novartis pink sheet market strength indicators, traders can identify Novartis AG entry and exit signals to maximize returns
Novartis Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novartis' price direction in advance. Along with the technical and fundamental analysis of Novartis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novartis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (1.34) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Novartis AG information on this page should be used as a complementary analysis to other Novartis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Novartis Pink Sheet analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |